{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T01:05:11Z","timestamp":1782263111278,"version":"3.54.5"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chemical Neuroanatomy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jchemneu.2017.06.007","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T12:10:14Z","timestamp":1498824614000},"page":"36-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Role of Vitamin D in Amyloid clearance via LRP-1 upregulation in Alzheimer\u2019s disease: A potential therapeutic target?"],"prefix":"10.1016","volume":"85","author":[{"given":"Parmi","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigna","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchemneu.2017.06.007_bib0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jalz.2011.02.004","article-title":"2011 Alzheimer\u2019s disease facts and figures","volume":"7","author":"Alzheimer\u2019s Association","year":"2011","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000334177","article-title":"Vitamin D-mentia: randomized clinical trials should be the next step","volume":"37","author":"Annweiler","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/joim.12279","article-title":"Vitamin D and cognition in older adults: updated international recommendations","volume":"277","author":"Annweiler","year":"2015","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0025","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.coph.2010.04.001","article-title":"Vitamin D: modulator of the immune system","volume":"10","author":"Baeke","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0030","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nm1438","article-title":"Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in- vivo","volume":"12","author":"Bateman","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0035","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","article-title":"Transport pathways for clearance of human Alzheimer\u2019s amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system","volume":"27","author":"Bell","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0040","first-page":"3","article-title":"Vitamin D \u2212 why does it matter? \u2212 defining Vitamin D deficiency and its prevalence","volume":"243","author":"Bischoff-Ferrari","year":"2012","journal-title":"Scand. J. Clin. Lab Invest. Suppl."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1523\/JNEUROSCI.21-01-00098.2001","article-title":"Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons","volume":"21","author":"Brewer","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuroscience.2013.12.064","article-title":"Decrease in age-related tau hyperphosphorylation and cognitive improvement following Vitamin D supplementation are associated with modulation of brain energy metabolism and redox state","volume":"262","author":"Briones","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-3940(03)00303-3","article-title":"1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons","volume":"343","author":"Brown","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0065","first-page":"4","article-title":"Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease","author":"Chesser","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0070","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1523\/JNEUROSCI.23-26-08844.2003","article-title":"In-Vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-\u03b2 metabolism and half-life","volume":"23","author":"Cirrito","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0075","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI25247","article-title":"P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model","volume":"115","author":"Cirrito","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0080","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0085","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1161\/01.STR.0000143452.85382.d1","article-title":"RAGE (yin) versus LRP (yang) balance regulates Alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier","volume":"35","author":"Deane","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0090","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1172\/JCI36663","article-title":"ApoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain","volume":"118","author":"Deane","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0095","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1517\/14712598.2012.688022","article-title":"Gantenerumab for the treatment of Alzheimer\u2019s disease","volume":"12","author":"Delrieu","year":"2012","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0100","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jsbmb.2004.03.062","article-title":"Towards a complete picture of splice variants of the gene for 25-hydroxyvitamin D31alpha-hydroxylase in brain and skin cancer","volume":"89\u201390","author":"Diesel","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0105","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1158\/1078-0432.CCR-04-1968","article-title":"Vitamin D(3) metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol","volume":"11","author":"Diesel","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","article-title":"RAGE, LRP-1, and amyloid-beta protein in Alzheimer\u2019s disease","volume":"112","author":"Donahue","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0115","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1523\/JNEUROSCI.2711-13.2014","article-title":"1\u03b1, 25-Dihydroxyvitamin D3 reduces cerebral amyloid-\u03b2 accumulation and improves cognition in mouse models of Alzheimer\u2019s disease","volume":"34","author":"Durk","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0120","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000350319","article-title":"Beta amyloid suppresses the expression of the Vitamin D receptor gene and induces the expression of the Vitamin D catabolic enzyme gene in hippocampal neurons","volume":"36","author":"Dursun","year":"2013","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0125","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jsbmb.2006.11.018","article-title":"1, 25-Dihydroxyvitamin D3 induces expression of the Wnt signaling co-regulator LRP5 via regulatory elements located significantly downstream of the gene\u2019s transcriptional start site","volume":"103","author":"Fretz","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0130","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s10072-012-1268-6","article-title":"Vitamin D inquiry in hippocampal neurons: consequences of vitamin D-VDR pathway disruption on calcium channel and the vitamin D requirement","volume":"34","author":"Gezen-Ak","year":"2013","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0135","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3233\/JAD-131970","article-title":"Why Vitamin D in Alzheimer\u2019s disease? The hypothesis","volume":"40","author":"Gezen-Ak","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuroscience.2016.01.041","article-title":"1, 25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in-vitro and in-vivo, enhancing A\u03b21-40 brain-to-blood efflux and peripheral uptake transport","volume":"322","author":"Guo","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0145","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0150","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0155","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jsbmb.2010.03.019","article-title":"The nuclear Vitamin D receptor controls the expression of genes encoding factors which feed the Fountain of Youth to mediate healthful aging","volume":"121","author":"Haussler","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0160","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.biochem.71.110601.135342","article-title":"Lipoprotein receptors in the nervous system","volume":"71","author":"Herz","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0165","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1002\/j.1460-2075.1988.tb03306.x","article-title":"Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor","volume":"7","author":"Herz","year":"1988","journal-title":"EMBO J."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0170","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0175","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/joim.12308","article-title":"Vitamin D and brain health: the need for Vitamin D supplementation and sensible sun exposure","volume":"277","author":"Holick","year":"2015","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0180","doi-asserted-by":"crossref","first-page":"15861","DOI":"10.1523\/JNEUROSCI.3272-11.2011","article-title":"Dynamic analysis of amyloid \u03b2-protein in behaving mice reveals opposing changes in ISF versus parenchymal A\u03b2 during age-related plaque formation","volume":"31","author":"Hong","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0185","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/gerona\/glu022","article-title":"Vitamin D in relation to cognitive impairment, cerebrospinal fluid biomarkers, and brain volumes","volume":"69","author":"Hooshmand","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0190","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neures.2006.07.006","article-title":"Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1\u201340) across the rat blood-brain barrier","volume":"56","author":"Ito","year":"2006","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0195","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2045-8118-8-20","article-title":"1\u03b1, 25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-\u03b2 peptide(1\u201340) from mouse brain across the blood-brain barrier","volume":"8","author":"Ito","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0200","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3233\/JAD-2009-1074","article-title":"Testing the neurovascular hypothesis of Alzheimer\u2019s disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition","volume":"17","author":"Jaeger","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0205","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jns.2015.06.009","article-title":"Vitamin D and cognitive function: the troms\u00f8 study","volume":"355","author":"Jorde","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0210","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1677\/ERC-09-0139","article-title":"Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment","volume":"17","author":"Krishnan","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0215","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3390\/cancers5041242","article-title":"Vitamin D is a multilevel repressor of wnt\/\u03b2-catenin signaling in cancer cells","volume":"5","author":"Larriba","year":"2013","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0220","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s004030050445","article-title":"Expression of Vitamin D3 25-hydroxylase (CYP27) mRNA after induction by vitamin D3 or UVB radiation in keratinocytes of human skin equivalents-a preliminary study","volume":"291","author":"Lehmann","year":"1999","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0225","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1615\/CritRevEukaryotGeneExpr.2013007147","article-title":"Vitamin D and microRNAs in bone","volume":"23","author":"Lisse","year":"2013","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0230","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/0891988708327888","article-title":"Serum 25-hydroxyvitamin D concentration and cognitive impairment","volume":"22","author":"Llewellyn","year":"2009","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0235","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3233\/JAD-2009-1080","article-title":"1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer\u2019s disease patients","volume":"17","author":"Masoumi","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0240","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0245","first-page":"118","article-title":"Vitamin D: the sunshine vitamin","volume":"3","author":"Nair","year":"2012","journal-title":"J Pharmacol Pharmacother."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0250","first-page":"5","article-title":"Increased in-vivo amyloid-\u03b242 production, exchange, and irreversible loss in presenilin mutations carriers","author":"Potter","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0255","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/nm1635","article-title":"Clearance of amyloid-beta by circulating lipoprotein receptors","volume":"13","author":"Sagare","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0260","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0265","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/354432a0","article-title":"Alzheimer\u2019s disease. In the beginning","volume":"354","author":"Selkoe","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0270","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer\u2019s amyloid-ss(1\u201340) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0275","doi-asserted-by":"crossref","first-page":"22091","DOI":"10.1074\/jbc.M110.102277","article-title":"Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearance","volume":"285","author":"Shinohara","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0280","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/NEN.0b013e3181f46e25","article-title":"Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging","volume":"69","author":"Silverberg","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0285","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/NEN.0b013e3181c8ad2f","article-title":"Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging","volume":"69","author":"Silverberg","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0290","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1172\/JCI81108","article-title":"Endothelial LRP1 transports amyloid-\u03b21-42 across the blood-brain barrier","volume":"126","author":"Storck","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0295","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1179\/1476830513Y.0000000080","article-title":"Vitamin D supplementation restores suppressed synaptic plasticity in Alzheimer\u2019s disease","volume":"17","author":"Taghizadeh","year":"2014","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0300","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s11095-006-0208-7","article-title":"Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid beta-peptide by the liver","volume":"23","author":"Tamaki","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0305","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1517\/14712598.2013.789856","article-title":"Bapineuzumab and solanezumab for Alzheimer\u2019s disease: is the amyloid cascade hypothesis still alive?","volume":"13","author":"Tayeb","year":"2013","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0310","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1074\/jbc.M806538200","article-title":"LRP1 controls intracellular cholesterol storage and fatty acid synthesis through modulation of Wnt signaling","volume":"284","author":"Terrand","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0315","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13195-016-0189-7","article-title":"Bapineuzumab for mild to moderate Alzheimer\u2019s disease in two global, randomized, phase 3 trials","volume":"8","author":"Vandenberghe","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0320","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1021\/bi972965+","article-title":"An AP-1 site in the nerve growth factor promoter is essential for 1, 25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts","volume":"37","author":"Veenstra","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0325","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.neurobiolaging.2011.12.038","article-title":"Vitamin D receptor and Alzheimer\u2019s disease: a genetic and functional study","volume":"33","author":"Wang","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0330","series-title":"a\u03b2 Metabolism in Alzheimer\u2019s Disease","first-page":"114","article-title":"Transport-clearance hypothesis for Alzheimer's disease and potential therapeutic implications","author":"Zlokovic","year":"2003"},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0335","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1471-4159.2010.07002.x","article-title":"Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer\u2019s amyloid \u03b2-peptide elimination from the brain","volume":"115","author":"Zlokovic","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0340","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1471-4159.2004.02385.x","article-title":"Clearing amyloid through the blood-brain barrier","volume":"89","author":"Zlokovic","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0345","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tins.2005.02.001","article-title":"Neurovascular mechanisms of Alzheimer\u2019s neurodegeneration","volume":"28","author":"Zlokovic","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jchemneu.2017.06.007_bib0350","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"}],"container-title":["Journal of Chemical Neuroanatomy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891061816302721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891061816302721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T23:57:19Z","timestamp":1569628639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891061816302721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":70,"alternative-id":["S0891061816302721"],"URL":"https:\/\/doi.org\/10.1016\/j.jchemneu.2017.06.007","relation":{},"ISSN":["0891-0618"],"issn-type":[{"value":"0891-0618","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Vitamin D in Amyloid clearance via LRP-1 upregulation in Alzheimer\u2019s disease: A potential therapeutic target?","name":"articletitle","label":"Article Title"},{"value":"Journal of Chemical Neuroanatomy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchemneu.2017.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}